Premium
Indigenous hepatitis E virus infection of a plasma donor in Germany
Author(s) -
Adlhoch C.,
Kaiser M.,
Pauli G.,
Koch J.,
Meisel H.
Publication year - 2009
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.2009.01211.x
Subject(s) - hepatitis e virus , virology , genotype , serology , polymerase chain reaction , biology , blood transfusion , virus , hepatitis e , alanine transaminase , hepatitis , antibody , immunology , gene , genetics , endocrinology
Background Although Europe is supposed to be non‐endemic for hepatitis E virus (HEV), locally acquired human cases are registered, and a relatively high prevalence for anti‐HEV was found in blood donors in some European countries. Transfusion–transmitted infections by contaminated blood products were reported in Japan and sporadically in Europe. Materials and Methods Several samples from a plasma donor were screened with a highly sensitive quantitative HEV real‐time polymerase chain reaction and the full‐length genome was generated. Serology was performed with two different commercially available ELISA kits. Results The full‐length genome sequence of human HEV was identified using samples from a plasma donor with acute self‐limiting hepatitis. Plasma donated 2 weeks before onset of elevated liver enzyme levels was already positive for HEV RNA (10 4 copies/ml). High viraemia (10 6 copies/ml) correlated with the detection of anti‐HEV IgM in the first blood sample with increased alanine transaminase levels. Phylogenetic analyses grouped the isolate within genotype 3, subtype 3f. Conclusion The sequence analyses and the epidemiological data revealed that the plasma donor was most probably infected with a swine HEV. This case supports the ongoing discussion of an obligatory HEV nucleic acid testing of blood products for special recipient risk groups.